Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tantai Zhao, Jiani Li, Yanbin Wang, Xiaojian Guo & Yun Sun. (2023) Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China. Annals of Medicine 55:1.
Read now
Read now
Articles from other publishers (22)
Helena M. A. Feenstra, Elon H. C. van Dijk, Thomas J. van Rijssen, Roula Tsonaka, Roselie M. H. Diederen, Carel B. Hoyng, Reinier O. Schlingemann & Camiel J. F. Boon. (2022) Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3. Graefe's Archive for Clinical and Experimental Ophthalmology 261:3, pages 659-668.
Crossref
Crossref
Hajime Onoe, Hiroyuki Shimada, Akiyuki Kawamura, Hiromi Hirosawa, Koji Tanaka, Ryusaburo Mori & Hiroyuki Nakashizuka. (2022) Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report. BMC Ophthalmology 22:1.
Crossref
Crossref
Joost Brinks, Elon H. C. van Dijk, Onno C. Meijer, Reinier O. Schlingemann & Camiel J. F. Boon. (2022) Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities. Acta Ophthalmologica 100:8, pages 946-959.
Crossref
Crossref
José Ignacio Fernández-Vigo, Verónica Gómez Calleja, José Joaquim de Moura Ramos, Jorge Novo-Bujan, Bárbara Burgos-Blasco, Lorenzo López-Guajardo, Juan Donate-López & Marcos Ortega-Hortas. (2022) Prediction of the response to photodynamic therapy in patients with chronic central serous chorioretinopathy based on optical coherence tomography using deep learning. Photodiagnosis and Photodynamic Therapy 40, pages 103107.
Crossref
Crossref
Marc J. Sirks, Elon H.C. van Dijk, Noa Rosenberg, Carla E.M. Hollak, Stamatios Aslanis, Chui Ming Gemmy Cheung, Itay Chowers, Chiara M. Eandi, K. Bailey Freund, Frank G. Holz, Peter K. Kaiser, Andrew J. Lotery, Kyoko Ohno‐Matsui, Giuseppe Querques, Yousif Subhi, Ramin Tadayoni, Charles C. Wykoff, Dinah Zur, Roselie M.H. Diederen, Camiel J.F. Boon & Reinier O. Schlingemann. (2022) Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care. Acta Ophthalmologica 100:7.
Crossref
Crossref
Alain Gaudric, Isabelle Audo, Catherine Vignal, Aude Couturier, Élise Boulanger-Scemama, Ramin Tadayoni & Salomon Yves Cohen. (2022) Non-vasogenic cystoid maculopathies. Progress in Retinal and Eye Research 91, pages 101092.
Crossref
Crossref
Taras KustrynOleg ZadorozhnyyIllia NasinnykAndrii KorolNatalya Pasyechnikova. (2022) Photodynamic Therapy with Chlorin e6 Derivative for Chronic Central Serous Chorioretinopathy (Pilot Study). Journal of Ocular Pharmacology and Therapeutics 38:7, pages 505-512.
Crossref
Crossref
Özge Yanık, Sibel Demirel, Figen Batıoğlu & Emin Özmert. (2022) A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy. Life 12:9, pages 1304.
Crossref
Crossref
Helena M. A. Feenstra, Leo C. Hahn, Thomas J. van Rijssen, Roula Tsonaka, Myrte B. Breukink, Jan. E. E. Keunen, Petrus J. H. Peters, Greet Dijkman, Eric H. Souied, Robert E. MacLaren, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Elon H. C. van Dijk & Camiel J. F. Boon. (2022) EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina 42:4, pages 721-729.
Crossref
Crossref
Thomas J. van Rijssen, Leo C. Hahn, Elon H.C. van Dijk, Roula TsonakaPaula ScholzMyrte B. BreukinkRocio Blanco-GaravitoEric H. SouiedJan E.E. KeunenRobert E. MacLarenGiuseppe QuerquesSascha Fauser, Susan M. DownesCarel B. HoyngCamiel J.F. Boon. (2021) RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina 41:10, pages 2122-2131.
Crossref
Crossref
Lieselotte Berger, Virginie Bühler & Suzanne Yzer. (2021) Central Serous Chorioretinopathy – an Overview. Klinische Monatsblätter für Augenheilkunde 238:09, pages 971-979.
Crossref
Crossref
Elon H.C. van Dijk & Camiel J.F. Boon. (2021) Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula. Progress in Retinal and Eye Research 84, pages 100955.
Crossref
Crossref
F.J. Moreno-Morillo, J.I. Fernández-Vigo, N. Güemes-Villahoz, B. Burgos-Blasco, L. López-Guajardo & J. Donate-López. (2021) Update on the management of chronic central serous chorioretinopathy. Archivos de la Sociedad Española de Oftalmología (English Edition) 96:5, pages 251-264.
Crossref
Crossref
F.J. Moreno-Morillo, J.I. Fernández-Vigo, N. Güemes-Villahoz, B. Burgos-Blasco, L. López-Guajardo & J. Donate-López. (2021) Actualización en el tratamiento de la coriorretinopatía serosa central crónica. Archivos de la Sociedad Española de Oftalmología 96:5, pages 251-264.
Crossref
Crossref
Thomas J. van Rijssen, Elon H. C. van Dijk, Paula Scholz, Robert E. MacLaren, Sascha Fauser, Susan M. Downes, Carel B. Hoyng & Camiel J. F. Boon. (2020) Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy. Graefe's Archive for Clinical and Experimental Ophthalmology 259:4, pages 905-910.
Crossref
Crossref
Manuel Paez-Escamilla, Mahima Jhingan, Denise S. Gallagher, Sumit Randhir Singh, Samantha Fraser-Bell & Jay Chhablani. (2021) Age-related macular degeneration masqueraders: From the obvious to the obscure. Survey of Ophthalmology 66:2, pages 153-182.
Crossref
Crossref
Stefano Da Pozzo, Pierluigi Iacono, Alessandro Arrigo & Maurizio Battaglia Parodi. (2021) The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy. Pharmaceuticals 14:2, pages 105.
Crossref
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Paula Scholz, Myrte B. Breukink, Greet Dijkman, Petrus J.H. Peters, Roula Tsonaka, Robert E. MacLaren, Susan M. Downes, Sascha Fauser, Camiel J.F. Boon & Carel B. Hoyng. (2020) Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial. American Journal of Ophthalmology 216, pages 80-89.
Crossref
Crossref
Gideon Nkrumah, Manuel Paez-Escamilla, Sumit Randhir Singh, Mohammed Abdul Rasheed, Dmitri Maltsev, Abhilash Guduru & Jay Chhablani. (2020) Biomarkers for central serous chorioretinopathy. Therapeutic Advances in Ophthalmology 12, pages 251584142095084.
Crossref
Crossref
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Małgorzata Kneba & Andrzej Grzybowski. (2019) Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy. BMC Ophthalmology 19:1.
Crossref
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Suzanne Yzer, Kyoko Ohno-Matsui, Jan E.E. Keunen, Reinier O. Schlingemann, Sobha Sivaprasad, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Felice Cardillo Piccolino, Jay K. Chhablani, Timothy Y.Y. Lai, Andrew J. Lotery, Michael Larsen, Frank G. Holz, K. Bailey Freund, Lawrence A. Yannuzzi & Camiel J.F. Boon. (2019) Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Progress in Retinal and Eye Research 73, pages 100770.
Crossref
Crossref
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Małgorzata Kneba & Andrzej Grzybowski. (2019) Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset. Journal of Clinical Medicine 8:9, pages 1398.
Crossref
Crossref